The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global PARP Inhibitor Biomarkers Service Market Research Report 2025
Synopsis
The global PARP Inhibitor Biomarkers Service market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for PARP Inhibitor Biomarkers Service is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for PARP Inhibitor Biomarkers Service is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for PARP Inhibitor Biomarkers Service in Hospital is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of PARP Inhibitor Biomarkers Service include Myriad Genetics, Inc., Hoffmann-La Roche AG, Invitae Corporation, NeoGenomics Laboratories, Inc. and BPS Bioscience, Inc., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for PARP Inhibitor Biomarkers Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding PARP Inhibitor Biomarkers Service.
Report Scope
The PARP Inhibitor Biomarkers Service market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global PARP Inhibitor Biomarkers Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the PARP Inhibitor Biomarkers Service companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Myriad Genetics, Inc.
Hoffmann-La Roche AG
Invitae Corporation
NeoGenomics Laboratories, Inc.
BPS Bioscience, Inc.
Segment by Type
BRCA 1 & 2 Testing
HRD Testing
HRR Testing
Others
Segment by Application
Hospital
Clinic
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of PARP Inhibitor Biomarkers Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global PARP Inhibitor Biomarkers Service market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for PARP Inhibitor Biomarkers Service is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for PARP Inhibitor Biomarkers Service is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for PARP Inhibitor Biomarkers Service in Hospital is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of PARP Inhibitor Biomarkers Service include Myriad Genetics, Inc., Hoffmann-La Roche AG, Invitae Corporation, NeoGenomics Laboratories, Inc. and BPS Bioscience, Inc., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for PARP Inhibitor Biomarkers Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding PARP Inhibitor Biomarkers Service.
Report Scope
The PARP Inhibitor Biomarkers Service market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global PARP Inhibitor Biomarkers Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the PARP Inhibitor Biomarkers Service companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Myriad Genetics, Inc.
Hoffmann-La Roche AG
Invitae Corporation
NeoGenomics Laboratories, Inc.
BPS Bioscience, Inc.
Segment by Type
BRCA 1 & 2 Testing
HRD Testing
HRR Testing
Others
Segment by Application
Hospital
Clinic
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of PARP Inhibitor Biomarkers Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global PARP Inhibitor Biomarkers Service Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 BRCA 1 & 2 Testing
1.2.3 HRD Testing
1.2.4 HRR Testing
1.2.5 Others
1.3 Market by Application
1.3.1 Global PARP Inhibitor Biomarkers Service Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global PARP Inhibitor Biomarkers Service Market Perspective (2019-2030)
2.2 PARP Inhibitor Biomarkers Service Growth Trends by Region
2.2.1 Global PARP Inhibitor Biomarkers Service Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 PARP Inhibitor Biomarkers Service Historic Market Size by Region (2019-2024)
2.2.3 PARP Inhibitor Biomarkers Service Forecasted Market Size by Region (2025-2030)
2.3 PARP Inhibitor Biomarkers Service Market Dynamics
2.3.1 PARP Inhibitor Biomarkers Service Industry Trends
2.3.2 PARP Inhibitor Biomarkers Service Market Drivers
2.3.3 PARP Inhibitor Biomarkers Service Market Challenges
2.3.4 PARP Inhibitor Biomarkers Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top PARP Inhibitor Biomarkers Service Players by Revenue
3.1.1 Global Top PARP Inhibitor Biomarkers Service Players by Revenue (2019-2024)
3.1.2 Global PARP Inhibitor Biomarkers Service Revenue Market Share by Players (2019-2024)
3.2 Global PARP Inhibitor Biomarkers Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by PARP Inhibitor Biomarkers Service Revenue
3.4 Global PARP Inhibitor Biomarkers Service Market Concentration Ratio
3.4.1 Global PARP Inhibitor Biomarkers Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by PARP Inhibitor Biomarkers Service Revenue in 2023
3.5 PARP Inhibitor Biomarkers Service Key Players Head office and Area Served
3.6 Key Players PARP Inhibitor Biomarkers Service Product Solution and Service
3.7 Date of Enter into PARP Inhibitor Biomarkers Service Market
3.8 Mergers & Acquisitions, Expansion Plans
4 PARP Inhibitor Biomarkers Service Breakdown Data by Type
4.1 Global PARP Inhibitor Biomarkers Service Historic Market Size by Type (2019-2024)
4.2 Global PARP Inhibitor Biomarkers Service Forecasted Market Size by Type (2025-2030)
5 PARP Inhibitor Biomarkers Service Breakdown Data by Application
5.1 Global PARP Inhibitor Biomarkers Service Historic Market Size by Application (2019-2024)
5.2 Global PARP Inhibitor Biomarkers Service Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America PARP Inhibitor Biomarkers Service Market Size (2019-2030)
6.2 North America PARP Inhibitor Biomarkers Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America PARP Inhibitor Biomarkers Service Market Size by Country (2019-2024)
6.4 North America PARP Inhibitor Biomarkers Service Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe PARP Inhibitor Biomarkers Service Market Size (2019-2030)
7.2 Europe PARP Inhibitor Biomarkers Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe PARP Inhibitor Biomarkers Service Market Size by Country (2019-2024)
7.4 Europe PARP Inhibitor Biomarkers Service Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific PARP Inhibitor Biomarkers Service Market Size (2019-2030)
8.2 Asia-Pacific PARP Inhibitor Biomarkers Service Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific PARP Inhibitor Biomarkers Service Market Size by Region (2019-2024)
8.4 Asia-Pacific PARP Inhibitor Biomarkers Service Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America PARP Inhibitor Biomarkers Service Market Size (2019-2030)
9.2 Latin America PARP Inhibitor Biomarkers Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America PARP Inhibitor Biomarkers Service Market Size by Country (2019-2024)
9.4 Latin America PARP Inhibitor Biomarkers Service Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa PARP Inhibitor Biomarkers Service Market Size (2019-2030)
10.2 Middle East & Africa PARP Inhibitor Biomarkers Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa PARP Inhibitor Biomarkers Service Market Size by Country (2019-2024)
10.4 Middle East & Africa PARP Inhibitor Biomarkers Service Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Myriad Genetics, Inc.
11.1.1 Myriad Genetics, Inc. Company Detail
11.1.2 Myriad Genetics, Inc. Business Overview
11.1.3 Myriad Genetics, Inc. PARP Inhibitor Biomarkers Service Introduction
11.1.4 Myriad Genetics, Inc. Revenue in PARP Inhibitor Biomarkers Service Business (2019-2024)
11.1.5 Myriad Genetics, Inc. Recent Development
11.2 Hoffmann-La Roche AG
11.2.1 Hoffmann-La Roche AG Company Detail
11.2.2 Hoffmann-La Roche AG Business Overview
11.2.3 Hoffmann-La Roche AG PARP Inhibitor Biomarkers Service Introduction
11.2.4 Hoffmann-La Roche AG Revenue in PARP Inhibitor Biomarkers Service Business (2019-2024)
11.2.5 Hoffmann-La Roche AG Recent Development
11.3 Invitae Corporation
11.3.1 Invitae Corporation Company Detail
11.3.2 Invitae Corporation Business Overview
11.3.3 Invitae Corporation PARP Inhibitor Biomarkers Service Introduction
11.3.4 Invitae Corporation Revenue in PARP Inhibitor Biomarkers Service Business (2019-2024)
11.3.5 Invitae Corporation Recent Development
11.4 NeoGenomics Laboratories, Inc.
11.4.1 NeoGenomics Laboratories, Inc. Company Detail
11.4.2 NeoGenomics Laboratories, Inc. Business Overview
11.4.3 NeoGenomics Laboratories, Inc. PARP Inhibitor Biomarkers Service Introduction
11.4.4 NeoGenomics Laboratories, Inc. Revenue in PARP Inhibitor Biomarkers Service Business (2019-2024)
11.4.5 NeoGenomics Laboratories, Inc. Recent Development
11.5 BPS Bioscience, Inc.
11.5.1 BPS Bioscience, Inc. Company Detail
11.5.2 BPS Bioscience, Inc. Business Overview
11.5.3 BPS Bioscience, Inc. PARP Inhibitor Biomarkers Service Introduction
11.5.4 BPS Bioscience, Inc. Revenue in PARP Inhibitor Biomarkers Service Business (2019-2024)
11.5.5 BPS Bioscience, Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global PARP Inhibitor Biomarkers Service Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of BRCA 1 & 2 Testing
Table 3. Key Players of HRD Testing
Table 4. Key Players of HRR Testing
Table 5. Key Players of Others
Table 6. Global PARP Inhibitor Biomarkers Service Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global PARP Inhibitor Biomarkers Service Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global PARP Inhibitor Biomarkers Service Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global PARP Inhibitor Biomarkers Service Market Share by Region (2019-2024)
Table 10. Global PARP Inhibitor Biomarkers Service Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global PARP Inhibitor Biomarkers Service Market Share by Region (2025-2030)
Table 12. PARP Inhibitor Biomarkers Service Market Trends
Table 13. PARP Inhibitor Biomarkers Service Market Drivers
Table 14. PARP Inhibitor Biomarkers Service Market Challenges
Table 15. PARP Inhibitor Biomarkers Service Market Restraints
Table 16. Global PARP Inhibitor Biomarkers Service Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global PARP Inhibitor Biomarkers Service Market Share by Players (2019-2024)
Table 18. Global Top PARP Inhibitor Biomarkers Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PARP Inhibitor Biomarkers Service as of 2023)
Table 19. Ranking of Global Top PARP Inhibitor Biomarkers Service Companies by Revenue (US$ Million) in 2023
Table 20. Global 5 Largest Players Market Share by PARP Inhibitor Biomarkers Service Revenue (CR5 and HHI) & (2019-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players PARP Inhibitor Biomarkers Service Product Solution and Service
Table 23. Date of Enter into PARP Inhibitor Biomarkers Service Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global PARP Inhibitor Biomarkers Service Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global PARP Inhibitor Biomarkers Service Revenue Market Share by Type (2019-2024)
Table 27. Global PARP Inhibitor Biomarkers Service Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global PARP Inhibitor Biomarkers Service Revenue Market Share by Type (2025-2030)
Table 29. Global PARP Inhibitor Biomarkers Service Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global PARP Inhibitor Biomarkers Service Revenue Market Share by Application (2019-2024)
Table 31. Global PARP Inhibitor Biomarkers Service Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global PARP Inhibitor Biomarkers Service Revenue Market Share by Application (2025-2030)
Table 33. North America PARP Inhibitor Biomarkers Service Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 34. North America PARP Inhibitor Biomarkers Service Market Size by Country (2019-2024) & (US$ Million)
Table 35. North America PARP Inhibitor Biomarkers Service Market Size by Country (2025-2030) & (US$ Million)
Table 36. Europe PARP Inhibitor Biomarkers Service Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. Europe PARP Inhibitor Biomarkers Service Market Size by Country (2019-2024) & (US$ Million)
Table 38. Europe PARP Inhibitor Biomarkers Service Market Size by Country (2025-2030) & (US$ Million)
Table 39. Asia-Pacific PARP Inhibitor Biomarkers Service Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 40. Asia-Pacific PARP Inhibitor Biomarkers Service Market Size by Region (2019-2024) & (US$ Million)
Table 41. Asia-Pacific PARP Inhibitor Biomarkers Service Market Size by Region (2025-2030) & (US$ Million)
Table 42. Latin America PARP Inhibitor Biomarkers Service Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Latin America PARP Inhibitor Biomarkers Service Market Size by Country (2019-2024) & (US$ Million)
Table 44. Latin America PARP Inhibitor Biomarkers Service Market Size by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa PARP Inhibitor Biomarkers Service Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Middle East & Africa PARP Inhibitor Biomarkers Service Market Size by Country (2019-2024) & (US$ Million)
Table 47. Middle East & Africa PARP Inhibitor Biomarkers Service Market Size by Country (2025-2030) & (US$ Million)
Table 48. Myriad Genetics, Inc. Company Detail
Table 49. Myriad Genetics, Inc. Business Overview
Table 50. Myriad Genetics, Inc. PARP Inhibitor Biomarkers Service Product
Table 51. Myriad Genetics, Inc. Revenue in PARP Inhibitor Biomarkers Service Business (2019-2024) & (US$ Million)
Table 52. Myriad Genetics, Inc. Recent Development
Table 53. Hoffmann-La Roche AG Company Detail
Table 54. Hoffmann-La Roche AG Business Overview
Table 55. Hoffmann-La Roche AG PARP Inhibitor Biomarkers Service Product
Table 56. Hoffmann-La Roche AG Revenue in PARP Inhibitor Biomarkers Service Business (2019-2024) & (US$ Million)
Table 57. Hoffmann-La Roche AG Recent Development
Table 58. Invitae Corporation Company Detail
Table 59. Invitae Corporation Business Overview
Table 60. Invitae Corporation PARP Inhibitor Biomarkers Service Product
Table 61. Invitae Corporation Revenue in PARP Inhibitor Biomarkers Service Business (2019-2024) & (US$ Million)
Table 62. Invitae Corporation Recent Development
Table 63. NeoGenomics Laboratories, Inc. Company Detail
Table 64. NeoGenomics Laboratories, Inc. Business Overview
Table 65. NeoGenomics Laboratories, Inc. PARP Inhibitor Biomarkers Service Product
Table 66. NeoGenomics Laboratories, Inc. Revenue in PARP Inhibitor Biomarkers Service Business (2019-2024) & (US$ Million)
Table 67. NeoGenomics Laboratories, Inc. Recent Development
Table 68. BPS Bioscience, Inc. Company Detail
Table 69. BPS Bioscience, Inc. Business Overview
Table 70. BPS Bioscience, Inc. PARP Inhibitor Biomarkers Service Product
Table 71. BPS Bioscience, Inc. Revenue in PARP Inhibitor Biomarkers Service Business (2019-2024) & (US$ Million)
Table 72. BPS Bioscience, Inc. Recent Development
Table 73. Research Programs/Design for This Report
Table 74. Key Data Information from Secondary Sources
Table 75. Key Data Information from Primary Sources
List of Figures
Figure 1. Global PARP Inhibitor Biomarkers Service Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global PARP Inhibitor Biomarkers Service Market Share by Type: 2023 VS 2030
Figure 3. BRCA 1 & 2 Testing Features
Figure 4. HRD Testing Features
Figure 5. HRR Testing Features
Figure 6. Others Features
Figure 7. Global PARP Inhibitor Biomarkers Service Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global PARP Inhibitor Biomarkers Service Market Share by Application: 2023 VS 2030
Figure 9. Hospital Case Studies
Figure 10. Clinic Case Studies
Figure 11. Others Case Studies
Figure 12. PARP Inhibitor Biomarkers Service Report Years Considered
Figure 13. Global PARP Inhibitor Biomarkers Service Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global PARP Inhibitor Biomarkers Service Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global PARP Inhibitor Biomarkers Service Market Share by Region: 2023 VS 2030
Figure 16. Global PARP Inhibitor Biomarkers Service Market Share by Players in 2023
Figure 17. Global Top PARP Inhibitor Biomarkers Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PARP Inhibitor Biomarkers Service as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by PARP Inhibitor Biomarkers Service Revenue in 2023
Figure 19. North America PARP Inhibitor Biomarkers Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America PARP Inhibitor Biomarkers Service Market Share by Country (2019-2030)
Figure 21. United States PARP Inhibitor Biomarkers Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada PARP Inhibitor Biomarkers Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe PARP Inhibitor Biomarkers Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe PARP Inhibitor Biomarkers Service Market Share by Country (2019-2030)
Figure 25. Germany PARP Inhibitor Biomarkers Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. France PARP Inhibitor Biomarkers Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. U.K. PARP Inhibitor Biomarkers Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Italy PARP Inhibitor Biomarkers Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Russia PARP Inhibitor Biomarkers Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Nordic Countries PARP Inhibitor Biomarkers Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific PARP Inhibitor Biomarkers Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific PARP Inhibitor Biomarkers Service Market Share by Region (2019-2030)
Figure 33. China PARP Inhibitor Biomarkers Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Japan PARP Inhibitor Biomarkers Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. South Korea PARP Inhibitor Biomarkers Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Southeast Asia PARP Inhibitor Biomarkers Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. India PARP Inhibitor Biomarkers Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Australia PARP Inhibitor Biomarkers Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America PARP Inhibitor Biomarkers Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America PARP Inhibitor Biomarkers Service Market Share by Country (2019-2030)
Figure 41. Mexico PARP Inhibitor Biomarkers Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Brazil PARP Inhibitor Biomarkers Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa PARP Inhibitor Biomarkers Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa PARP Inhibitor Biomarkers Service Market Share by Country (2019-2030)
Figure 45. Turkey PARP Inhibitor Biomarkers Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Saudi Arabia PARP Inhibitor Biomarkers Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Myriad Genetics, Inc. Revenue Growth Rate in PARP Inhibitor Biomarkers Service Business (2019-2024)
Figure 48. Hoffmann-La Roche AG Revenue Growth Rate in PARP Inhibitor Biomarkers Service Business (2019-2024)
Figure 49. Invitae Corporation Revenue Growth Rate in PARP Inhibitor Biomarkers Service Business (2019-2024)
Figure 50. NeoGenomics Laboratories, Inc. Revenue Growth Rate in PARP Inhibitor Biomarkers Service Business (2019-2024)
Figure 51. BPS Bioscience, Inc. Revenue Growth Rate in PARP Inhibitor Biomarkers Service Business (2019-2024)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
